UgoWork obtient un financement de 51 millions de dollars pour transformer l’industrie de la manutention grâce à ses solutions énergétiques avancées
July 31, 2024 08:00 ET
|
UgoWork
QUÉBEC, 31 juill. 2024 (GLOBE NEWSWIRE) -- UgoWork™, un fournisseur de premier plan de solutions avancées de stockage d'énergie pour les véhicules de manutention, a annoncé aujourd'hui la...
UgoWork raises $51M to further transform material handling with its advanced energy solutions
July 31, 2024 08:00 ET
|
UgoWork
QUEBEC, July 31, 2024 (GLOBE NEWSWIRE) -- UgoWork™, a premier provider of advanced energy storage solutions for material handling equipment, today announced the closing of $51M as part of its Series...
Memo Therapeutics increases Series C financing to CHF 45 million
May 07, 2024 07:00 ET
|
Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics increases Series C financing to CHF 45 million Additional CHF 20 million raised from new investors Ysios Capital and Kurma Partners as well as from existing...
Memo Therapeutics increases Series C financing to CHF 45 million
May 07, 2024 02:00 ET
|
Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics increases Series C financing to CHF 45 million Additional CHF 20 million raised from new investors Ysios Capital and Kurma Partners as well as from existing...
Diabeloop - Key Player in Therapeutic AI Applied to Insulin Delivery - Announces 70 Million Euros New Financing Round to Accelerate Its International Expansion
June 02, 2022 08:30 ET
|
Diabeloop SA
PARIS, June 02, 2022 (GLOBE NEWSWIRE) -- Diabeloop secures 70 million euros to pursue its solid and sustained growth strategy. The automated insulin delivery pioneer, develops machine-learning...
eureKARE participates in DNA Script’s $200 Million Series C Financing
January 04, 2022 06:21 ET
|
eureKARE
eureKARE participates in DNA Script’s $200 Million Series C Financing Fundraise will accelerate commercial launch of revolutionary enzymatic DNA printing technology Luxembourg and Paris, France –...
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
May 27, 2021 07:00 ET
|
Pulmocide
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide
May 27, 2021 02:00 ET
|
Jeito Capital
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide Jeito selects Pulmocide as its fourth investment since launching the fundPulmocide is a late-stage biopharma...
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
May 27, 2021 02:00 ET
|
Pulmocide
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...
AZTherapies Closes $26.3 Million Series C Preferred Equity Financing
October 17, 2019 08:32 ET
|
AZTherapies, Inc.
BOSTON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced the closing of a $26.3 million Series C...